E. Ercan Et Al. , "Titanium platelet–rich fibrin (T-PRF) as high-capacity doxycycline delivery system," Clinical Oral Investigations , vol.26, no.8, pp.5429-5438, 2022
Ercan, E. Et Al. 2022. Titanium platelet–rich fibrin (T-PRF) as high-capacity doxycycline delivery system. Clinical Oral Investigations , vol.26, no.8 , 5429-5438.
Ercan, E., Suner, S. C., Sılan, C., Yılmaz, S., Sıddıkoğlu, D., Şahiner, N., ... Tunalı, M.(2022). Titanium platelet–rich fibrin (T-PRF) as high-capacity doxycycline delivery system. Clinical Oral Investigations , vol.26, no.8, 5429-5438.
Ercan, ESRA Et Al. "Titanium platelet–rich fibrin (T-PRF) as high-capacity doxycycline delivery system," Clinical Oral Investigations , vol.26, no.8, 5429-5438, 2022
Ercan, ESRA Et Al. "Titanium platelet–rich fibrin (T-PRF) as high-capacity doxycycline delivery system." Clinical Oral Investigations , vol.26, no.8, pp.5429-5438, 2022
Ercan, E. Et Al. (2022) . "Titanium platelet–rich fibrin (T-PRF) as high-capacity doxycycline delivery system." Clinical Oral Investigations , vol.26, no.8, pp.5429-5438.
@article{article, author={ESRA ERCAN Et Al. }, title={Titanium platelet–rich fibrin (T-PRF) as high-capacity doxycycline delivery system}, journal={Clinical Oral Investigations}, year=2022, pages={5429-5438} }